Compare CNTN & QUIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTN | QUIK |
|---|---|---|
| Founded | 2017 | 1988 |
| Country | United States | United States |
| Employees | N/A | 51 |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 178.5M | 196.7M |
| IPO Year | 2021 | 1997 |
| Metric | CNTN | QUIK |
|---|---|---|
| Price | $1.75 | $9.27 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | ★ 729.5K | 171.3K |
| Earning Date | 11-11-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.10 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $20,112,000.00 |
| Revenue This Year | N/A | $73.33 |
| Revenue Next Year | N/A | $16.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.66 | $5.28 |
| 52 Week High | $5.27 | $24.33 |
| Indicator | CNTN | QUIK |
|---|---|---|
| Relative Strength Index (RSI) | 31.57 | 33.62 |
| Support Level | N/A | $8.72 |
| Resistance Level | $3.80 | $10.14 |
| Average True Range (ATR) | 0.13 | 0.45 |
| MACD | -0.07 | -0.19 |
| Stochastic Oscillator | 3.49 | 16.31 |
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.